APP-based Medical Device for Education and Training of Inhalation Technique
NCT07145632 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2025-08-28
Summary
Primary aim: To investigate if app-based education and training of inhalation technique improves the rate of successful inhalation techniques compared with control group at 6-12 weeks follow-up visit.
Secondary aims: To evaluate the feasibility, usability, and safety of the investigational during the study period.
Study design: Two-armed, parallel-designed, individual single-blinded stratified randomisation by inhaler (DPI/MDI/both DPI and MDI) controlled trial with assignment (1:1) to (1) standard care and app-based education and training of inhalation technique or (2) standard education of inhalation technique over 6-12 weeks.
Subjects: Subjects from the age of 16 years with documented diagnosis of asthma and/or COPD, daily treated with dry powder inhaler (DPI) or metered dose inhaler (MDI), or both, will be invited to voluntarily participate. Exclusion criteria is age \<16 years, no access to use BankID or similar electronic personal identification service, not using smartphone of type Android or iPhone, plan to stop use DPI and/or MDI the following 6-12 weeks from inclusion. No able to independently handle and inhale through DPI or MDI device.
Total sample size: Eighty subjects (females and males) with daily treatment for COPD or asthma will be sufficient, based on the assumption of 25% percentage improvement in success rate of correct inhalation technique in the interventional group compared with control group (75% versus 50%) with 80% power at 5% significance level, including dropouts at 6-12 weeks follow-up visit.
Intervention: At the baseline visit patients will be randomised to app-based intervention consisting of education and training of inhalation technique of all inhalers used on daily basis (the inhalation app-module). Stratified randomisation based on type of inhaler(s); MDI, DPI or both MDI and DPI will be applied. The intervention is the inhalation app-module, which is a medical device that is embedded the AsthmaTuner app. The AsthmaTuner app is a CE-marked cloud-based system, provided by MediTuner AB in Stockholm, Sweden. The intervention group will be instructed to use the inhalation app-module on daily basis to improve their inhalation technique.
Control group: Standard education of inhalation technique using list of standardised criteria and non-app-based education of inhaler technique.
Endpoints: Primary endpoint is the rate of subjects with successful inhalation techniques based on subjective critical endpoints (CIP Table 2) and the following objective endpoints at the 6-12 weeks follow up visit:
* DPI: PIF \> 30 L/Min, time to PIF \<0.5 seconds measured with the investigational device.
* MDI: inspiration time (\> 3 seconds) and PIF less than 60 L/Min measured with the investigational device.
Procedures: At baseline, a trained respiratory nurse will subjectively assess and train each patient's inhalation technique according to defined criteria of device handling (standard education). The AsthmaTuner app is downloaded to a smartphone or tablet computer (Ipad) that is wirelessly (Bluetooth) connected to a home spirometer. In this study the Bluetooth spirometer AsthmaTuner from MIR will be used. Education and training of inhalation technique will include measurement of inhalation flow with an adjustable resistance mounted on the spirometer, Airflow Trainer (MIR). The app gives instruction to set the resistance, so it corresponds to the selected inhaler. Questionnaires and interviews will collect information about the feasibility, safety and experienced usability of the investigational device.
Analysis: The rate of subjects with successful inhalation technique at 6-12-week visit determined by fulfilling objective and subjective critical endpoints in intention-to-treat approach. The effect of using the inhalation app-module will be analysed with logistic regression analysis across randomisation groups. The secondary analysis of feasibility and the experienced benefit of using the inhalation app-module in clinical practice and for patient's education and training of inhalation technique is estimated on a Likert scale from 1 (not at all) to 5 (strongly agree) and presented as mean and median scores.
Conditions
- Asthma (Part 1)
- COPD
Interventions
- DEVICE
-
App-based education and training of inhalation technique
The use of MDI or DPI requires different inhalation techniques and flows, which makes correct inhalation technique more challenging if patient use different types of inhaler devices. Healthcare providers may assess inhalation technique by observation and in addition PIF may be measured by manual meter. However, this does not capture all relevant information about patient's ability to correctly inhale medication and handle prescribed inhaler(s) and do not give instant and automated feedback on the inhalation technique to user. For instance, DPI users should reached a sufficiently high PIF within the first 0.4 seconds \[18\] and MDI users inhalation time should exceed 4 seconds in adults (2-3 seconds in children) in order to optimize lung deposition of the aerosol during a low PIF \[19\]. The app-based inhalation medical device gives automated feedback on inspiratory flows that are specific DPI and MDI devices.
Sponsors & Collaborators
-
Uppsala University Hospital
collaborator OTHER - lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-01
- Primary Completion
- 2027-06-01
- Completion
- 2027-06-01
Countries
- Sweden
Study Locations
More Related Trials
-
Asymmetrical High Flow Nasal Cannula and End-Expiratory Lung Impedance
NCT06674629 ·Status: COMPLETED
-
PEEP as Rescue Therapy for Asthmatics With Elevated BMI
NCT02696980 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of EPAP Device on Emphysema and Lung Bullae
NCT04742114 ·Status: UNKNOWN ·Phase: NA
-
Spiration Valve System 9 mm European Post Market Evaluation Study
NCT03008226 ·Status: UNKNOWN
-
A Study of Pressure and Flow Characteristics During Inspiration and Expiration Using BreatheMAX® in Healthy Subjects
NCT02847416 ·Status: COMPLETED ·Phase: NA
-
Assessment of Cough and Wheeze With Breath Sound Documenting Device
NCT00711399 ·Status: COMPLETED
-
Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording
NCT00644462 ·Status: UNKNOWN
-
Investigation of Heart Failure Status Over Time Using Respiratory Parameters
NCT00494117 ·Status: COMPLETED
-
Evaluation of the Free Flow Medical Lung Tensioning Device System for the Treatment of Severe Emphysema
NCT04520152 ·Status: COMPLETED ·Phase: NA
-
Symptomatic Treatment of Excessive Dynamic Airway Collapse Using Daytime Portable Continuous Positive Airway Pressure
NCT02763631 ·Status: COMPLETED ·Phase: NA
-
Effect of Mentoring on Endotracheal Tube Exchange Using a New Device
NCT02763189 ·Status: TERMINATED ·Phase: NA
-
Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19
NCT04331366 ·Status: COMPLETED ·Phase: NA
-
Distribution of Pulmonary Ventilation With the Modified Pachon Incentive vs. Branded Respiratory Incentive
NCT05532748 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Regional Ventilation Distribution Using Electrical Impedance Tomography During Weaning From Mechanical Ventilation
NCT05726513 ·Status: UNKNOWN ·Phase: NA
-
Endobronchial Silicone Valve for Patients With Emphysema
NCT07097896 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Cough Strength in Patients With Tracheostomies
NCT02566512 ·Status: COMPLETED ·Phase: NA
-
Predicting Success of Decannulation Using Wearable-derived Physiology
NCT07198425 ·Status: NOT_YET_RECRUITING
-
PEP-device for Treatment of Swimming-induced Pulmonary Edema (SIPE)
NCT05227222 ·Status: RECRUITING ·Phase: NA
-
Airflow Perturbation Device (APD) for the Evaluation of Pulmonary and Sleep Disorders
NCT03054116 ·Status: COMPLETED
-
Cough Peak Flow for Extubation Prediction
NCT02847221 ·Status: COMPLETED
-
Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic
NCT04654481 ·Status: TERMINATED ·Phase: NA
-
Electrical Activity of the Diaphragm During the Weaning Period
NCT01411722 ·Status: COMPLETED ·Phase: PHASE2
-
High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients
NCT06897319 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Proof of Concept Study of Electrical Discharge Produced Nitric Oxide for Inhalation
NCT02305550 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Lung Volume Reduction After Catheter-based CV Measurement in Patients With Heterogeneous Emphysema and Complete Interlobar Fissures
NCT01902732 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3